Skip to main content

Table 4 Early smoking impaired smoking cessation (after adjusting smoking index)

From: Early smoking lead to worse prognosis of COPD patients: a real world study

Variables

Early smoking (n = 104)

Late smoking (n = 104)

P-value

Age, years

68(61, 71)

69(65,73)

0.035

Male, %

99

98.1

0.561

BMI, kg/m2

22.08(19.36,24.15)

21.21(18.70,24.50)

0.451

Smoking index ,packets/year

40(33,60)

40(33,60)

0.999

Duration of smoking cessation, years

9(3,13)

10(3, 19)

0.787

Spirometry(post-bronchodilation)

   

FEV1% predicted

26(19.9,37)

31.1(21,42.3)

0.013

FEV1/FVC, %

34.1(27.3,42.2)

38(30,46.4)

0.010

mMRC

3(2,4)

3(2,4)

0.212

CAT

23(16,27)

28.5(25,34)

0.252

Frequency of AEs in the last 12 months, times

1(1,3)

2(1,3)

0.011

Frequency of admission for AECOPD in the last 12 months, times

1(1,2)

2(1,3)

0.087

Laboratory investigations on admission

   

WBC count, x 109/L

7.51(6.3,10.4)

7.18(5.89,9.58)

0.428

Neutrophil count, x 109/L

5.31(4.25,8.36)

5.52(4.02,7.46)

0.098

Eosinophil count, x 109/L

0.14(0.06,0.24)

0.11(0.03,0.23)

0.046

CRP, mg/l

13(3.92,32.5)

9.77(3.89,21.65)

0.861

PCT, mg/l

0.08(0.05, 0.14)

0.08(0.05, 0.15)

0.957

BNP, pg/ml

120(50, 490)

117(50, 555)

0.685

PaCO2, mm/Hg

50(43,63)

50(43,62.8)

0.638

PaO2, mm/Hg

71(57,85)

65(53,79)

0.351

SaO2, %

924(88,96)

92 (87,96)

0.542

ICS therapy during stable stage, %

75

75

1

Triple therapy during stable stage, %

30.8

24

0.277

  1. Notes: Date are presented as median(IQR) or n(%). FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; mMRC: modified Medical Research Council; CAT: COPD Assessment Test; TB: tuberculosis; AE: Acute Exacerbation; AECOPD: Acute Exacerbation of Chronic Obstructive Pulmonary Disease; CRP:C-reactive protein; PCT: Procalcitonin; BNP: brain natriuretic peptide; PaO2: partial pressure of oxygen in artery; PaCO2: partial pressure of carbon dioxide in arterial blood; SaO2: oxygen saturation in arterial blood; ICS: inhaled corticosteroids